Columbia neuroscientists have identified a genetic mutation that fends off Alzheimer's in people at high risk and could lead to a new way to protect people from the disease.
With funding from the Ultra-rare Gene-based Therapy Network, scientists at Columbia and the n-Lorem Foundation will create tailor-made gene-based therapies for people with rare forms of ALS.
A study led by Columbia and Cornell researchers finds, surprisingly, that anticoagulants do not prevent recurrent strokes in people with one type of heart condition.
Depression appears to be associated with mild cognitive impairment and an increased risk of dementia; José A. Luchsinger, MD, MPH was senior author of the study, published in the Archives of Neurology.
A team of scientists from The New York Stem Cell Foundation Laboratory and CUMC has developed a technique that may prevent the inheritance of mitochondrial diseases in children.